Provided by Tiger Trade Technology Pte. Ltd.

Accendra Health Inc

1.20
-0.1100-8.40%
Post-market: 1.20-0.0019-0.16%19:36 EDT
Volume:1.69M
Turnover:2.07M
Market Cap:92.29M
PE:-0.30
High:1.31
Open:1.28
Low:1.18
Close:1.31
52wk High:5.69
52wk Low:0.9337
Shares:76.90M
Float Shares:56.51M
Volume Ratio:0.53
T/O Rate:2.99%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.9457
EPS(LYR):-14.3179
ROE:-198.35%
ROA:0.64%
PB:-0.17
PE(LYR):-0.08

Loading ...

Accendra Health files $200M mixed securities shelf

TIPRANKS
·
Jul 16

Accendra Health - May Offer up to $200 Mln in Securities - SEC Filing

THOMSON REUTERS
·
Jul 16

Ascendis to Showcase Advances in Treatment of Achondroplasia at ICCBH 2026

GlobeNewswire
·
Jun 26

Accendra Health Reports Expiration of Exchange Offers, Final Tender Results

MT Newswires Live
·
Jun 24

Accendra Health exchange offers draw 99%+ tenders for 2029 and 2030 notes

Reuters
·
Jun 24

Accendra Health bond exchange draws 99%+ early tenders, sets June 15 settlement date

Reuters
·
Jun 16

Accendra Health Announces Early Results of Exchange Offers

MT Newswires Live
·
Jun 10

Accendra Health says holders tender 99%+ of notes in exchange offer for new secured debt

Reuters
·
Jun 10

Accendra Health Launches Offering to Exchange Senior Notes

MT Newswires Live
·
May 23

Accendra Health launches exchange offer for 2029 and 2030 senior notes

Reuters
·
May 23

Accendra Health shareholders approve amended 2023 omnibus incentive plan at annual meeting

Reuters
·
May 15

Accendra Health (ACH) Q1 Loss Narrows Challenging Bearish Profitability Narratives

Simply Wall St.
·
May 13

Accendra Health Is Maintained at Outperform by Baird

Dow Jones
·
May 12

Accendra Health price target raised to $6 from $5 at Baird

TIPRANKS
·
May 12

Press Release: Chemtrade Logistics Income Fund Announces Results for the First Quarter of 2026; Reiterates 2026 Adjusted EBITDA Guidance of $485 to $525 Million

Dow Jones
·
May 12

Accendra Health Shares Gain on Narrowed Loss, Adjusted EPS Beat

Dow Jones
·
May 11

Accendra Health Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 11

Accendra Health backs FY26 guidance for net revenue and adjusted EBITDA

TIPRANKS
·
May 11

Accendra Health Inc - to Receive $300 Mln New Revolving Credit Facility Due 2030 - SEC Filing

THOMSON REUTERS
·
May 11

Accendra Health Inc - Enters Commitment Letter With Holders of 2029 and 2030 Senior Notes - SEC Filing

THOMSON REUTERS
·
May 11